- In
Canada and Brazil, ETST is lab testing three new cannabidiol formulations,
developing two more CBD products and conducting studies on its Hygee
device for women
- In the
U.S., it is researching CBD’s impact on breast cancer and immune cells
- ETST
is focused on the development of innovative products to reach its goal of
becoming a world leader in the CBD space, with three new CBD formulas
being developed under a provisory patent
Earth Science Tech, Inc. (OTC: ETST) is testing in Canada
and Brazil a diverse mix of cannabidiol (CBD) formulations, including a
superfood formula (http://ibn.fm/0y5lu).
It is also conducting pre-launch lab studies of a medical device scheduled to
be marketed internationally (http://ibn.fm/8iIOO).
ETST is a biotech company based in Doral, Florida, marketing
and developing CBD products for the pharmaceutical and nutraceutical fields.
The company manufactures, markets and distributes its own cannabinoid products,
including capsules and oils. ETST has revamped its line of CBD products and
will extend its line of raw dark chocolates with three new flavors in
conjunction with joint venture partner Karmavore Superfoods. An anticipated
launch is planned for the third quarter of 2018 (http://ibn.fm/aM8s0).
In Canada, the company is testing three new CBD IP
formulations. They include a neuron protector and a breast protector. R&D
is being conducted by the Centre de Developpement bioalimentaire du Quebec
(CDBQ) or Quebec Agrifood Innovation Center (QAIC). An additional formulation will
include a natural protective agent that will extend shelf life. A third product
is a superfood that includes a mix of hemp oil and a highly potent antioxidant.
In Quebec, the company is also clinically testing its Hygee MSN-2 medical
device for detection of sexually transmitted infections (STIs) in women at the
Clinique Santé Amitié.
ETST is developing two new products in Brazil through a
joint venture with Bionatus Laboratrio Botnico of Brazil and its Canadian
division, Bionatus Botanical Laboratories, Inc. The products are Propovit,
enriched with ETST hemp oil, and a reformulation of Bionatus’ product featuring
CBD.
In the U.S., it is conducting studies with the University of
Central Oklahoma of high grade full spectrum CBD on breast cancer and immune
cells.
ETST holds several wholly owned subsidiaries. Cannabis
Therapeutics is an emerging biotechnology company. KannaBidioiD manufactures
and distributes in the recreational sector. Earth Science Foundation, Inc., is
becoming a non-profit and accepts grants and donations to conduct additional
studies. Earth Science Pharmaceutical develops medical diagnostic tools and
vaccines. ETST also recently formed subsidiary Canno Inno Laboratories Inc., a
strategic Montreal, Canada-based company that provides ETST with access to
government grants.
For more information, visit the company’s website at www.EarthScienceTech.com
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
